{name}
{subtitle}
Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
city
~46 mi. (Shepparton, Australia, +39 more cities)
facility
Novartis Investigative Site
condition
Fallopian Tube Carcinoma, +3 more conditions
drug
alpelisib, +1 more drug
Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Nivolumab in Patients With Advanced Melanoma
city
~46 mi. (Shepparton, Australia, +10 more cities)
facility
Goulburn Valley Health
biomarker
PD-L1 Expression (TC < 1%), +1 more biomarker
drug
nivolumab, +1 more drug
drug type
immunotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
city
~83 mi. (Albury, Australia, +89 more cities)
facility
Border Medical Oncology Research Unit
biomarker
ER Positive, +1 more biomarker
drug
giredestrant, +1 more drug
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
city
~83 mi. (East Albury, Australia, +165 more cities)
facility
Border Medical Oncology Research Unit Albury Wodonga Regional Cancer Centre /ID# 231311
biomarker
del(11)(q10), +27 more biomarkers
drug
navitoclax, +1 more drug